Abstract -The biosynthetic pathway of tetrahydrobiopterin (BH 4 ) from dihydroneopterin triphosphate (NH 2 P 3 ) was studied in fresh as well as heat-treated human liver extracts. The question of NAD(P)H dependency for the formation of sepiapterin was examined. NH 2 P 3 was converted by fresh extracts to sepiapterin in low quantities (2% conversion) in the absence of exogenously added NADPH as well as under conditions that ensured the destruction of endogenous, free NAD(P)H. The addition of NADPH to the fresh liver extracts stimulated the synthesis of BH 4 to a much higher yield (17% conversion), and the amount of sepiapterin formed was reduced to barely detectable levels. In contrast, the heat-treated extract (enzyme A2 fraction) formed sepiapterin (1.3% conversion) only in the presence and not in the absence of NADPH. These results indicate that sepiapterin may not be an intermediate on the pathway leading to BH 4 biosynthesis under normal~vivo conditions. Rather, sepiapterin may result from the breakdown of an as yet unidentified intermediate that is actually on the pathway. It is speculated that NH 2 P 3 may be converted to a diketo-tetrahydropterin intermediate (or an equivalent tautomeric structure) by a mechanism involving an intramolecular oxidoreduction reaction. A diketo-tetrahydropterin intermediate could be converted to 5,6-dihydrosepiapterin, which also has a tetrahydropterin ring system and can be converted directly to BH 4 by sepiapterin reductase. This proposed pathway can explain how the tetrahydropterin ring system can be formed without sepiapterin, dihydrobiopterin, or dihydrofolate reductase being involved in BH 4 biosynthesis~vivo.
INTRODUCTION
Despite a number of studies on tetrahydrobiopterin (BH 4 ) biosynthesis in mammals, several controversial aspects have yet to be explained. BH 4 is the cofactor for phenylalanine, tyrosine, and tryptophan hydroxylases (Kaufman, 1974; Lovenberg et~., 1978) and it has been suggested that BH 4 plays an important role in regulating the synthesis of the biogenic amine neurotransmitters . Errors in BH 4 biosynthesis and metabolism have been extensively studied in the rare childhood disease known as BH 4 -deficient hyperphenylalaninemia (also referred to as atypical phenylketonuria) (Niederwieser et~., 1982a) as well as in certain neurological and psychiatric disorders ). A more complete understanding of the enzymatic steps in BH 4 biosynthesis could help explain a potential involvement of altered BH 4 metabolism in certain disease processes.
Most available evidence suggests that the first reaction in mammalian BH 4 biosynthesis involves the conversion of guanosine triphosphate (GTP) to dihydroneopterin triphosphate (NH 2 P 3 ) by a single enzyme, GTP cyclohydrolase I. However, Gal and co-workers (1978 a, b) have proposed that in rat brain, GTP is converted by a cyclohydrolase to a pyrimidine intermediate, which is transformed by a synthetase enzyme to the quinoid (q-) form of NH 2 P 3 • Our recent studies on BH 4 biosynthesis in human liver (Blau and Niederwieser, 1983) do not support a two-enzyme hypothesis for NH 2 P 3 formation in mammals, since no pyrimidine intermediate could be detected after the reaction of GTP with purified human GTP cyclohydrolase I.
The enzymatic reactions involved in the formation of BH 4 from NH 2 P 3 are even more controversial. Work in several laboratories using chicken kidney (Tanaka et~., 1981) , ratand human liver (H~usermann et 21., 1981) , and Drosophila (Krivi and Brown, 1979; Dorsett et ., 1982) has suggested that NH 2 P 3 is converted through some intermediate "X" to L-sepiapterin. Evidence has also been presented that sepiapterin is an intermediate in BH 4 biosynthesis in rat brain (Kapatos et~., 1982) . However, whether sepiapterin synthesis requires NAD(P)H (Figure 1 ) or what the exact structure is for compound "X" is not clear among various laboratories. For instance, Tanaka and co-workers (1981) reported that NH 2 P 3 was converted to compound "X" by a heat-stable, magnesium-dependent enzyme, A2. It was suggested that "X" was converted to sepiapterin by the heat-labile enzyme, Al, which was reported to be NAD(P)H dependent. Conversely, Otsuka and co-workers (1980) reported sepiapterin formation without the addition of NAD(P)H. Regarding the potential NAD(P)H dependency (Figure 1 ) of sepiapterin formation from NH 2 P 3 , it is puzzling that NAD(P)H should be considered necessary since there is no net difference in the redox balance between NH 2 P 3 and sepiapterin. Also, it is not clear why the reported (Tanaka et~., 1981; Hausermann et~., 1981) percentage conversion of NH 2 P 3 to "X" or sepiapterin is so low in most systems.
In the proposed BH 4 biosynthetic pathway having sepiapterin as an intermediate, sepiapterin can be converted to dihydrobiopterin (BH 2 ) by sepiapterin reductase in the presence of NAD(P)H (see references in Figure 1 ). According to this scheme (Kaufman, 1967) , BH 2 is converted to BH 4 by dihydrofolate reductase (DHFR), a reaction that also requires intermediates in BH 4 biosynthesis, novel work was presented by Duch and co-workers (1983) that demonstrated the formation of BH 4 in the presence of sufficient methotrexate (MTX) to inhibit DHFR completely. This implied that BH 4 biosynthesis could occur without sepiapterin and BH Z as intermediates, and that there may be two possible pathways in vivo. Indeed, they have proposed (Nichol et~., 1983 ) that sepiapterin is not on the main biosynthetic pathway. Also, G&l and co-workers (1978 a,b) have proposed a pathway for BH 4 biosynthesis that doesn't involve sepiapterin (Figure 1 ). Accordin91y, there is some doubt about the involvement of sepiapterin as an intermediate in BH 4 biosynthesis (Nichol et~., 1983; .
Therefore, the following controversial questions remain: 1) Is the formation of sepiapterin from NH Z P 3 dependent on NAD(P)H, in spite of the equivalent redox state of NH Z P 3 and sepiapterin; Z) What is a possible explanation for the very low percentage conversion of NHzP3 to either "X" or sepiapterin; and 3) Fi 1 ure 1.-Various proposals for biosynthetl~pathways from dihydr?neopterin.triph?sphate (1 to sepiapterin (Z) and tetrahydrobiopterln (3). In the formatlon of seplapterln, the involvement of NADPH is controversial. Tetrahydrobiopterin formation has also been shown to occur without sepiapterin as an intermediate (Z pathways on right). Gal and coworkers (1978a,b) have suggested that dihydroneopterin triphosphate exists in the quinoid form (q-NHZP3) and is converted to quinoid dihydrobiopterin (q-BHZ) without requiring NADPH.
could lead to sepiapterin formation. Our studies on BH 4 biosynthesis using human liver extracts and the enzyme A2 fraction have attempted to clarify some of these issues. We selected a human system for synthesis studies because of the known difference in pterin metabolism in humans as compared to lower mammals such as the rat. Specifically, neopterin has only been detected in man {Fukushima and Nixon, 1980} and monkeys but not in the lower mammals tested thus far. This suggests that there is a fundamental difference between primates and certain lower mammals in the regulation of the enzymatic steps after NH 2 P 3 , which is our rationale for selecting a human system for the study of BH 4 biosynthesis.
EXPERIMENTAL PROCEDURES

Materials
All pterins except dihydroneopterin triphosphate {NH 2 P 3 } were purchased from Dr. B. Schircks Laboratory, Wettswil A.A., Switzerland. NH 2 P 3 was prepared enzymatically by incubation {90 min at 42 0 C in a total volume of 0.5 ml} of 0.2 mM GTP, 0. Human liver was obtained from traffic accident victims, frozen within 1 hour, and stored at -70 0 C. All other reagents were commercially available.
Purification of enzymes GTP cyclohydrolase I from E. coli was purified according to Yim and Brown {1976} and was used to generate the substrate NH 2 P 3 as described above.
The "standard extract" used for biosynthesis studies was prepared in the cold by the following procedures. Human liver was homogenized in 3 volumes of 25 mM Tris-HCl {pH 7.4}. After centrifugation at 27,000 x g for 45 min, the supernatant was fractionated with ammonium sulfate between 40 and 65% saturation. The supernatant was applied to a Sephadex G-25 column that was equilibrated with the same buffer. The initial fractions from the gel column were pooled to comprise the "standard extract". The combination of the ammonium sulfate and G-25 column steps should remove most of the endogenous, free NAD{P}H.
A fraction containing the heat stable enzyme, A2, was prepared according to Tanaka et~. {1981}, with the following modification. The "standard extract" was heated at 80 0 C for 5 min. The supernatant was used as a source of the A2 enzyme. Sepiapterin reductase was partially purified from human liver according to the method of Sueoka and Katoh {1982}, except that only the first two column steps were performed.
Biochemical assays
The reaction mixture for studying NH 2 P 3 transformations contained the following (pH 7.4), 20 4M NHl3' 14.0 mM MgC1 2 and the fresh or heat-treated "standard extract" (enzyme A2). This mixture was incubated for 15 min at 42 0 C at which time it was divided into 2 parts. One part was immediately treated at 100 0 C for 5 minutes to stop the reaction, centrifuged and ana1yzed for sepiapterin and "X" by high-pressure liquid chromatography (HPLC). The other part was immediately subjected to manganese dioxide (Mn0 2 ) oxidation and ana1yzed for neopterin, biopterin and pterin content by HPLC, as described below.
To test for the influence of oxygen on the reaction products, certain samples were reacted under anaerobic conditions. Briefly, nitrogen was bubbled through the samples prior to starting the reaction and glucose oxidase (40 U/m1) and glucose (0.06 M, final concentration) were added to consume any residual oxygen as previously described (Fan and Brown, 1978) .
Protein content was measured by the method of Bradford (1976) , using bovine gamma globulin as a standard.
Pterin oxidation methods and HPLC analysis
For measuring neopterin, biopterin and pterin ,in"the'~eaction products, 200 41 of each sample was acidified with 1.0 N HC1 (pH should be between 1 and 2) and oxidized by exposure to 5 mg of Mn0 2 for 5 min. The Mn0 2 and protein were removed by centrifugation and 10 41 of the supernatant were ana1yzed by HPLC. Native fluorescence (excitation: 350 nm, emission: 450 nm) was determined after reverse-phase chromatography as previously described in detail (Niederwieser et~., 1982b) .
For the measurement of sepiapterin and "X", a reverse-phase (Lichrosorb RP-18;5 micron, Merck) HPLC system was used with a Kontron SFM 23/8 fluorescence spectrophotometer (excitation: 425 nm, emission: 530 nm). The concentration of sepiapterin and "X" was quantitated by integration of peak area in comparison with authentic sepiapterin.
RESULTS
Formation of sepiapterin and "X" in the absence of added NAD(P)H Incubation of NHzP3 with the "standard extract" (Table 1 ) in the absence of NADPH resu lted in the format ion of sepi apter in and another f1 uorescent compound 1abe 11 ed "X", as detected by fluorescence (425/530 nm) after heat inactivation of the reaction and subsequent HPLC (Figure 2 ). Sepiapterin production was linear during the 15 minute reaction and 2% of the NH 2 P 3 was converted (Table 1 ). The formation of sepiapterin and "X" in this human system was totally dependent on the presence of Mg 2 +, which has also been demonstrated in nonhuman systems (Krivi and Brown, 1979; Tanaka et~., 1981) . The HPLC elution profile (Figure 2) shows that the major product eluting at 11.5 minutes has a retention time that is identical to authentic sepiapterin (standard tracing not shown). To substantiate the identity of sepiapterin formed from NH 2 P 3 , purified sepiapterin reductase and NADPH were added after the 15 minute reaction. After an additional 15 minutes, no sepiapterin could be detected and as expected, dihydrobiopterin was formed (Sueoka and Katoh, 1982) . Thus, it is reasonable to assume that this peak at 11.5 minutes is sepiapterin. The reaction product at (Niederwieser et al., 198Z) as well as the differential iodine oxidation procedure to differentTate-between reduced and oxidized pterins (Fukushima and Nixon, 1980) . Both methods indicated that greater than 90% of the biopterin was in the fully reduced, tetrahydro form. *** "Standard extract" was prepared in the following manner. homogenized, fractionated with ammonium sulfate (40-65%) and column chromatography. This "standard extract was incubated synthesized NH2P3 under various conditions.
Human liver was subjected to G-Z5 with enzymatically system and the same absorption characteristics as the "X" obtained by Dorsett et~. (1982) when they incubated NH z P 3 with an ammonium sulfate fraction (40-60%) of extracts from Drosophila heads. Our "X" in Figure Z could also be formed by heating the enzymatically synthesized NH Z P 3 for 40 minutes at 1000C, which are the same as the conditions described by Dorsett et~. (198Z) for the chemical formation of their "X". In our hands, after the enzymatic formation of the reaction products, "X" could be detected when the reaction was terminated by heating at 1000C for 5 minutes; this has also been reported by Dorsett et~. (1982) . However, when we terminated the reaction with methanol to precipitate protein, no "X" was detected, whereas sep i apter in was st i 11 present in the same amount (see Discussion).
Seplapterin formation after the removal of endogenous In order to ensure that all endogenous NAD(P} and destroyed, the following experiments ware performed. NAD(P)H NAD(P}H in the "standard extract" was After Sephadex G-Z5 chromatography, which should essentially exclude small molecules not tightly bound to proteins, the "standard extract" of human liver was pretreated at 37 0 C for 15 minutes in the presence of O.OZ U NADase, 0.005 U Old Yellow Enzyme, 1 U superoxide dismutase, and Z U catalase. That these enzymes were indeed active in the presence of the "standard extract" was tested according to published procedures (Kaplan, 1955; Abramovitz and Massey, 1976) . The Old Yellow Enzyme, a diaphorase, should effectively catalyze the oxidation of NAD(P)H to NAD(P)+, while NADase should irreversibly degrade NAD(P)+. Superoxide dismutase and catalase were added as scavengers of superoxide (0 2 ) and hydrogen peroxide (H Z 0 2 ), respectively, produced by the diaphorase reaction. Incubation of NH Z P 3 with this pretreated "standard extract" (Table 2 ) produced the same quantity of reaction products (sepiapterin and "X") as the incubation of the "standard extract" without pretreatment ( 
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RETENTION TIME (mln) Figure 2 . Fluorescence detection after HPLC separation of sepiapterin and "X". These reactlon products resulted from the incubation of the "standard extract" with NHZP3 (Table I, I ). 50 41 out of 500 ul were injected in a 15% methanol/water mobile phase (0.8 ml/min) that was changed to 20% methanol/water at 10 minutes for a more rapid elution of "X", which has similar retention characteristics as the compound "X" proposed by Dorsett et~l., (1982) (see Results). Human 1iver was subjected to G-25 with enzymatica11y
Effects of NAD(P)H and various oxidation conditions on reaction products To quantitate biopterin formation during the "standard~extract" reaction with NH Z P 3 (Table 1 ) a portion of the post-reaction mixture was oxidized with MnO Z under acid conditions and measured by fluorescence (350/450 nm) after HPLC (see methods). After MnO Z acid oxidation and HPLC, pterin formation could also be detected by fluorescence (350/450 nm) under certain reaction conditions. The results listed in Table 1 show that the incubations with the "standard extract" in the absence of NAD(P)H (where sepiapterin formation was maximal) yielded predominantly pterin and little biopterin. Essentially the same results were obtained under the conditions of NAD(P)H destruction (Table 2 ). However, in the presence of NAD(P)H (2.5 mM final concentration), the "standard extract" converted 17% of the NH Z P 3 to biopterin and no pterin was formed. Analysis of the reaction products in the presence of NAD(P)H using e1ectrochemical detection for reduced pterins (Niederwieser et il., 198Zb) as well as the differential iodine oxidation method of Fukushima and Nixon (1980) demonstrated that greater than 90% of the biopterin formed was in the fully reduced, tetrahydro form.
With regard to sepiapterin and "X" formation, incubation of the ·standard extract" with NAD(P)H (where BH 4 synthesis is maximal) produced little or no sepiapterin and "X" (Table 1) To obtain more information about the chemical nature of "X", the MnO Z acid oxidation was performed after "X" was isolated from other reaction products by HPLC. After the oxidation, no pterin was detected. Furthermore neither "X" nor any other fluorescent compound could be detected.
Tetrahydropterin intermediates in BR 4 biosynthesis
Effect of heat treatment of "standard extract" on reaction products
The enzyme fraction AZ from human liver was formed by heating the "standard extract" in the manner described by Tanaka et~. (1981) and Yoshioka et~. (1983) . The profile of the reaction products with or without the inclusion of NADPH in the reaction mixture was the opposite of the profile when the "standard extract" was used. When AZ was reacted with NH Z P 3 and MgC1 z in the absence of NADPH, a significant amount of "X" was formed during the reaction and pterin could be detected after acid MnO Z oxidation (Table 1) . In contrast, when NADPH (Z.5 mM final concentration) was included in the reaction, a relatively large amount of sepiapterin was formed and the amount of "X" was diminished. In this case (with NADPH), pterin could not be detected after acid MnO Z oxidation (Table 1) . No biopterin was formed in either the presence or absence of NADPH, presumably because enzymes after AZ on the BH 4 biosynthetic pathway were inactivated by heating (Tanaka~~., 1981) . Therefore, it is probable that under conditions using the enzyme AZ fraction, NH Z P 3 is transformed into some intermediate(s) on the BH 4 biosynthetic pathway that cannot react further.
DISCUSSION
149
The different biosynthetic pathways for BH 4 biosynthesis from NH Z P 3 that have been proposed are shown in Figure 1 . With the exception of the proposal by Gal et~. (1978 a,b) , which involves transformation of GTP to quinoid-NH Z P 3 and subsequently into quinoid-BH Z (Figure l,f) , the existence of NH Z P 3 as an intermediate appears to be undisputed. The conversion of NHzP3 to sepiapterin requires the elimination of the oxygen-triphosphate from NHzP3' the inversion at the secondary hydroxyl function in position Z' of the side chain, and the (formal) oxidation of the 1'-OH group to an oxo function. It is important to note that the conversion of NH Z P 3 to sepiapterin does not involve a net change in the redox balance between the two compounds, a point also noted by Krivi and Brown (1979) . Nevertheless, in three of the pathways (Figure 1, b,c,d ), NAD(P)H is proposed to be necessary; in one case (pathway d) it plays merely a catalytic role. Nicho1 et~. (1983) propose the "direct" conversion of NHzP3 to BH 4 without sepiapterin as an intermediate, which clearly requires reducing equivalents. The proposal of Gal and co-workers (1978 a, b) (pathway f) involves the conversion of q-NH Z P 3 to q-BH Z ' and this process does require reducing equivalents, even though they reported that added NADPH was not necessary.
This controversy of NAD(P)H dependency led us to examine sepiapterin formation in our BH 4 biosynthetic system from human liver extracts. It has been proposed, but not tested directly, that the enzymes following NH Z P 3 in BH 4 biosynthesis are rate-limiting because neopterin can only be detected in man and monkeys, but not in the lower mammals that have been tested thus far. Indeed, recent experiments in our laboratory have shown that NH Z P 3 can be detected in human liver but not rat liver. When using the fresh human liver extract, the conversion of NH Z P 3 to biopterin was approximately 17% (Table 1) and essentially all biopterin was in the tetrahydro form as determined by both the differential iodine oxidation method (Fukushima and Nixon, 1980 ) and e1ectrochemica1 detection of reaction products (Niederwieser et~., 198Zb) after HPLC. Thus, BH 4 with essentially no detectable sepiapterin. When NADPH was not added to the reaction, sepiapterin formation was linear for the duration of the reaction, although only 2% of NH 2 P 3 was measured as sepiapterin (Table 1 ). Under conditions which should ensure the elimination of any endogenous, free NADPH present in the reaction with the fresh extract, the same amount (2%) of sepiapterin was also detected (Table 2 ). These results indicate that sepiapterin can be formed in the absence of NADPH, however the yield is much lower than for BH 4 • It is likely that in the absence of NADPH, sepiapterin is formed from the degradation of another intermediate that is generated during the reaction. The nature of this postulated intermediate is discussed below.
A remaining question is why several groups have reported that the formation of sepiapterin from NH 2 P3 is NADPH-dependent when there is no net change in the redox balance between the two compounds. A possible rationale for these reports is that reduced pyridine nucleotides might react nonenzymatically with intermediates such as those proposed by Tanaka et~. (1981) or Dorsett et~. (1982) . Our experiments using the heat-treated "standard extract" that yields enzyme fraction A2 (Tanaka et~., 1981) support this concept. Enzyme fraction A2 with or without NADPH is not capable of forming BH 4 , presumably because the remaining enzymes involved in BH 4 synthesis have been destroyed. Tanaka and co-workers (1981) have proposed that enzyme A2 can form the postulated intermediate, 1',2'-dioxopropyl-dihydropterin (referred to as "diketo-dihydropterin"), shown on the left side of Figure 3 . They further propose that the diketo-dihydropterin can be converted by a heat labile enzyme fraction Al to sepiapterin in a process that is NADPH dependent. In contrast to our results with the "standard extract", the reaction of enzyme A2 with NH 2 P 3 in the absence of NADPH produced no sepiapterin (Table 1) , whereas the inclusion of NADPH did cause the production of sepiapterin (1.3% conversion of NH 2 P 3 ). Thus, it seems that the enzyme A2 causes the production of an intermediate that can react with NADPH to form sepiapterin. No sepiapterin was detectable when NADPH was not included in the reaction mixture. It is possible that the NADPH-dependent formation of sepiapterin that was observed by Tanaka and co-workers (1981) was the result of nonenzymatic reaction with NADPH, however the involvement of another NADPH-dependent enzyme in the formation of certain intermediates after NH 2 P 3 cannot be ruled out by our studies. Based on our current results and the evidence of Nichol and co-workers (1983) (1982) who studied sepiapterin formation in rat brain, it seems likely that the radioactive counts they measured as sepiapterin by HPLC may have actually been another compound that co-chromatographed with sepiapterin in their HPLC system. Later discussion on the nature of an intermediate that could degrade to sepiapterin will expand on this point.
Studies by Krivi and Brown (1979) are also relevant to the point of sepiapterin formation from an intermediate after reaction with NADPH. Their studies on the incorporation of label from either R or S NADPH into sepiapterin demonstrated a rather low selectivity for either form such that no stereochemical configuration was preferred. This lack of stereochemical specificity is not characteristic for enzyme reactions and may indicate that nonenzymatic sensitive to oxidation by 02' Table 2 shows that under anaerobic conditions the formation of sepiapterin and "X" are markedly reduced, indicating the possibility that oxidation of some other compound may be responsible for the appearance of these compounds.
The characteristics of "X" formed in our human liver biosynthetic system are similar to those reported by Dorsett and co-workers (1982) in their biosynthetic studies using extracts from Drosophila heads. Our "X" had similar retention characteristics on the reverse-phase HPLC system, showed an identical absorption spectrum, and could also be generated nonenzymatically by heating NHl3. The fact that "X" is only formed when the reaction is terminated by heating and not when methanol precipitation is employed indicates that "X" probably results from chemical degradation of some primary product that is formed enzymatically from NH 2 P3' Since the amount of sepiapterin formed is invariant whether heating or methanol is used to terminate the reaction, "X" is probably not formed from sepiapterin.
Some additional information can be gained from studying the effects of oxidation of reaction products under acid conditions. In general, exposure of tetrahydro-or dihydropterins that have no keto function in. the l' position of the side chain to Mn0 2 under acid conditions (pH between 1 and 2) causes·oxidation without side chain cleavage, and the resulting products are fluorescent at 350/450 nm (Niederwieser~~., 1982b). Thus, when BH 4 is formed by the standard extract and oxidized with Mn0 2 under acid conditions, only biopterin is formed and there is no side chain cleavage to form pterin (Table 1) . However, when dihydropterins that have a keto function in the l' position of the side chain (e.g., sepiapterin) are exposed to acid oxidation, no pterin or any other fluorescent compound can be detected at either of the two pairs of wavelenth settings (350/450 nm or 425/530 nm). In our experiments, the isolation of "X" by HPLC and subsequent exposure to Mn0 2 acid oxidation did not produce either pterin or other fluorescent compounds. Therefore, the pterin that is formed after Mn0 2 acid oxidation of the reaction products generated by the standard extract in the absence of NADPH cannot be generated by the breakdown of sepiapterin or "X", but must be generated from some other intermediate. When NADPH is included in the reaction mixture and the mixture is oxidized as above, only BH 4 is detectable and pterin is absent. This indicates that there is probably not a significant accumulation of an intermediate that can yield pterin after oxidation when NADPH is included and BH 4 is being synthesized by the "standard extract".
The question arises as to what type of intermediate could NH 2 P 3 be transformed into that could be a common link for the formation of sepiapterin, "X", and pterin (after Mn0 2 acid oxidation). Figure 3 depicts our proposal for the existence of tetrahydropterin intermediates in BH 4 biosynthesis and the rationale for our conclusions are presented below. It is conceivable that NH 2 P 3 could be converted directly to a pterin compound having a tetrahydropterin ring system by an internal oxidoreduction reaction involving the transfer of reducing equivalents from the side chain to the pterin ring. This might occur either subsequent to or concomitant with the elimination of the triphosphate moiety. A likely structure for this compound is l',2'-dioxopropyl-tetrahydropterin (referred to as "diketo-tetrahydropterin" in Figure 3 ). The 2'-position of diketo-tetrahydropterin could be reduced by a side chain reductase reaction to form 5,6-dihydrosepiapterin, which also has a tetrahydropterin ring system (the correct chemical name is 6-lactoyl-tetrahydropterin).
o
Either of these compounds could yield sepiapterin through nonenzymatic reactions. Sepiapterin could be formed from diketo-tetrahydropterin by an internal rearrangement, since these compounds are of equivalent redox state. A chemical oxidation of 5,6-dihydrosepiapterin could also yield sepiapterin. It is possible that the radioactivity detected as sepiapterin by Kapatos and co-workers (1982) in their HPLC system was actually 5,6-dihydrosepiapterin, which could co-chromatograph with sepiapterin, although in our hands, the two compounds can be separated by using different chromatographic conditions from what they employed. With regard to diketo-dihydropterin (compound "X") proposed by Tanaka and co-workers (1980) , it seems feasible that this compound could be an oxidative by-product of our proposed diketo-tetrahydropterin intermediate. Certainly, the exposure of this potential intermediate to Mn0 2 acid oxidation could lead to side chain cleavage and pterin formation (Table 1) , which was demonstrated for the postulated diketo-dihydropterin intermediate (Tanaka et~., 1981; Hausermann et~., 1981) .
The previous information supports our proposal that NH 2 P 3 can be converted to a diketo-tetrahydropterin intermediate by a mechanism involving an intramolecular oxidoreduction reaction. There are examples of this type of rearrangement in sugar chemistry, such as the Lobry de Bruyn-Alberda van Ekenstein transformation (Speck, 1968) . This type of intramoleclular oxidoreduction reaction was originally proposed by Pfleiderer (1975 Pfleiderer ( ,1979 to explain the chemical formation of sepiapterin from BH 4 • Thus, it seems likely that diketo-tetrahydropterin and 5,6-dihydrosepiapterin are intermediates in BH 4 biosynthesis. Our proposal for the existence of these tetrahydropterin intermediates (Figure 3 ) may help explain some of the current controversies regarding mammalian BH 4 biosynthesis.
